Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Paine

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Proteomics|September 17, 2008
A gel-free MS-based quantitative proteomic approach accurately measures cytochrome P450 protein concentrations in human liver microsomesMichael Zhuo Wang, Judy Qiju Wu, Jennifer B Dennison, et al.
Frontiers in Pharmacology|July 28, 2023
Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countriesDallas J Smith, Huichang Bi, Josias Hamman, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 12, 2025
Corrigendum to 'A gut response: Application of human enteroid monolayers to probe the mechanism of the goldenseal-mediated inhibition of metformin intestinal absorption' [The Journal of Pharmacology and Experimental Therapeutics 392 (2025) 103597]Christopher M Arian, Eimear T O'Mahony, Preston K Manwill, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
Developing User Personas to Aid in the Design of a User-Centered Natural Product-Drug Interaction Information Resource for ResearchersRichard D Boyce, Isabelle Ragueneau-Majlessi, Jingjing Yu, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 22, 2025
A gut response: Application of human enteroid monolayers to probe the mechanism of the goldenseal-mediated inhibition of metformin intestinal absorptionChristopher M Arian, Eimear T O'Mahony, Preston K Manwill, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 1999
Molecular and physical mechanisms of first-pass extractionS D Hall, K E Thummel, P B Watkins, et al.
Clinical Pharmacology and Therapeutics|May 16, 2018
ITC Commentary on Metformin Clinical Drug-Drug Interaction Study Design That Enables an Efficacy- and Safety-Based Dose Adjustment DecisionMaciej J Zamek-Gliszczynski, Xiaoyan Chu, Jack A Cook, et al.
Clinical Pharmacology and Therapeutics|May 28, 2020
Intestinal P-gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development ImplicationsMaciej J Zamek-Gliszczynski, Mitesh Patel, Xinning Yang, et al.
Clinical Pharmacology and Therapeutics|May 25, 2022
Clinical Relevance of Hepatic and Renal P-gp/BCRP Inhibition of Drugs: An International Transporter Consortium PerspectiveKunal S Taskar, Xinning Yang, Sibylle Neuhoff, et al.
Plos Neglected Tropical Diseases|August 1, 2012
Pharmacology of DB844, an orally active aza analogue of pafuramidine, in a monkey model of second stage human African trypanosomiasisJohn K Thuita, Michael Z Wang, John M Kagira, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Proteomics|September 17, 2008
A gel-free MS-based quantitative proteomic approach accurately measures cytochrome P450 protein concentrations in human liver microsomesMichael Zhuo Wang, Judy Qiju Wu, Jennifer B Dennison, et al.
Frontiers in Pharmacology|July 28, 2023
Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countriesDallas J Smith, Huichang Bi, Josias Hamman, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 12, 2025
Corrigendum to 'A gut response: Application of human enteroid monolayers to probe the mechanism of the goldenseal-mediated inhibition of metformin intestinal absorption' [The Journal of Pharmacology and Experimental Therapeutics 392 (2025) 103597]Christopher M Arian, Eimear T O'Mahony, Preston K Manwill, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
Developing User Personas to Aid in the Design of a User-Centered Natural Product-Drug Interaction Information Resource for ResearchersRichard D Boyce, Isabelle Ragueneau-Majlessi, Jingjing Yu, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 22, 2025
A gut response: Application of human enteroid monolayers to probe the mechanism of the goldenseal-mediated inhibition of metformin intestinal absorptionChristopher M Arian, Eimear T O'Mahony, Preston K Manwill, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 1999
Molecular and physical mechanisms of first-pass extractionS D Hall, K E Thummel, P B Watkins, et al.
Clinical Pharmacology and Therapeutics|May 16, 2018
ITC Commentary on Metformin Clinical Drug-Drug Interaction Study Design That Enables an Efficacy- and Safety-Based Dose Adjustment DecisionMaciej J Zamek-Gliszczynski, Xiaoyan Chu, Jack A Cook, et al.
Clinical Pharmacology and Therapeutics|May 28, 2020
Intestinal P-gp and Putative Hepatic OATP1B Induction: International Transporter Consortium Perspective on Drug Development ImplicationsMaciej J Zamek-Gliszczynski, Mitesh Patel, Xinning Yang, et al.
Clinical Pharmacology and Therapeutics|May 25, 2022
Clinical Relevance of Hepatic and Renal P-gp/BCRP Inhibition of Drugs: An International Transporter Consortium PerspectiveKunal S Taskar, Xinning Yang, Sibylle Neuhoff, et al.
Plos Neglected Tropical Diseases|August 1, 2012
Pharmacology of DB844, an orally active aza analogue of pafuramidine, in a monkey model of second stage human African trypanosomiasisJohn K Thuita, Michael Z Wang, John M Kagira, et al.
Pageof 18